Saudi Arabia's Food and Drug Authority has introduced NADR, a regulatory framework designed to accelerate the development and approval of medicines for rare diseases in the Kingdom. The move aims to give patients faster access to treatments that address conditions affecting only small numbers of people.
NADR sets out the regulatory pathway for rare disease drugs, bringing together several supporting programs under one framework. the authority does not charge fees for orphan drug designation, the breakthrough medicine program, conditional approval, priority review, or the verification and abridged procedure.
A fee does apply for scientific and regulatory advice. However, significant fee reductions or full waivers may be granted in certain cases, including for investigational drugs and some requests related to advanced therapy medicinal products (ATMPs). This structure is intended to lower barriers for developers working on treatments for rare conditions.
Why it matters
Rare diseases often receive limited attention from drug developers because they affect relatively few patients, which can make research and approval processes costly and slow. By removing fees for key regulatory steps and offering waivers for others, the framework encourages more companies to bring these specialized medicines to the Saudi market.
For residents and families in the Kingdom living with rare conditions, the framework could eventually translate into wider availability of treatments and shorter waiting times for new therapies. It also aligns with broader national efforts to strengthen the healthcare system and expand patient access to advanced medical care.
Stay updated with the latest news, events, sports updates, business insights, real estate and lifestyle stories on Saudi Living — the leading online platform for residents, expats, and visitors in Saudi Arabia.
Follow Saudi Living for daily updates:
- Instagram - @saudiliving
- X - @saudiliving
- Facebook - @saudiliving
- YouTube - @saudiliving
Up Next

Saudi Summer Programs 2026 Open Doors for Youth
Explore Saudi Arabia's 2026 summer training and talent programs, from HRDF Maharat funding to KAUST, Aramco, Mawhiba and Riyadh camps.
Aug 13,2026
Najla Al-Tuwaijri Named Princess Nourah University President
Najla Al-Tuwaijri has been appointed president of Princess Nourah University in Riyadh by royal approval, bringing a strong academic background in pharmaceutical sciences.
Aug 13,2026
Saudi Schools Reopen 23 August 2026 for New Year
Schools across most of Saudi Arabia reopen on Sunday, 23 August 2026, while Makkah, Madinah, Jeddah, and Taif begin on 30 August. Full return dates inside.
Aug 12,2026
Saudi Virtual Care Expands Access to Health Services
Saudi virtual care grows via Seha Virtual Hospital, with telehealth pricing, licensing rules, and over 16 million appointments driven in 2025.
Aug 11,2026Related Stories
Don't Miss Similar Listings
Be the first to know when new stories on this topic are published.














